MDS Podcast

International Parkinson and Movement Disorder Society
undefined
Oct 18, 2019 • 0sec

Introduction and functional movement disorders | Congress 2019

Did you miss the MDS Congress in Nice, or do you just want an overview of highlights from the International Congress as well as a look forward at new ventures? Dr. Schaefer introduces the MDS Congress 2019 special issue, which features interviews with experts in various fields of movement disorders at the MDS Congress 2019. In this first issue, Dr. Sara Schaefer interviews Dr. Kathrin LaFaver about notable research in functional movement disorders, activities of the MDS Functional Movement Disorders Study Group, and more.
undefined
Oct 18, 2019 • 0sec

Education at the MDS | Congress 2019

As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Ronald Postuma about all of the educational offerings through the MDS, as well as new projects of the MDS Education Committee.
undefined
Oct 14, 2019 • 0sec

Definition and characteristics of early onset PSP: A different disease?

In this interview with Dr. Edwin Jabbari, we highlight the results of his study on the definition and genetic and neuropathological characteristics of early onset progressive supranuclear palsy. The full study is available on the September 2019 issue of the Movement Disorders journal. Read the article
undefined
Aug 30, 2019 • 0sec

MDS PSP criteria in practice: From clinical phenotyping to pathological diagnosis

Dr. Farwa Ali discusses with Dr. Sara Schaefer the results of her study on the use of the MDS criteria for PSP with the MAX rules and their clinical implications, as well as the challenges of the phenotype variability of this disease in clinical practice and research. Read the article
undefined
Aug 6, 2019 • 0sec

Iron imaging of substantia nigra in Parkinson's disease: A possible biomarker?

Dr. Niels Bergsland discusses with Dr. Michele Matarazzo the results of the article he recently published in the Movement Disorders journal on longitudinal iron imaging in the substantia nigra in PD and in its different regions. Read the article
undefined
Jun 28, 2019 • 0sec

Patient vs. care partner assessment of cognitive disability in Parkinson's: Who's more accurate?

Benjamin Deck discusses with Dr. Schaefer the article he recently published in the Movement Disorders Clinical Practice on the patient vs. care partner assessment of cognition in Parkinson's disease. Read the article
undefined
Jun 6, 2019 • 0sec

Long-term outcomes of focused ultrasound in essential tremor

Dr. Jin Woo Chang shares the results of 4-year follow-up of MR-guided focused ultrasound thalamotomy in essential tremor. In his article, recently published in the Movement Disorders journal, he analyzes whether the efficacy of this procedure is sustained over time. Read the article
undefined
Apr 30, 2019 • 0sec

When should dopaminergic treatment be initiated in Parkinson's disease?

Dr. Ruth Schneider discusses with Dr. Sara Schaefer about the article she recently published in the Movement Disorders Clinical Practice that investigates the outcomes of early vs delayed start of dopaminergic medication in Parkinson's disease. Read the article
undefined
Mar 22, 2019 • 0sec

Advanced therapies for Parkinson's disease: Are they all the same?

Dr. K. Ray Chaudhuri discusses with Dr. Michele Matarazzo his article on the differences between subthalamic nucleus DBS, intrajejunal levodopa and apomorphine infusion in Parkinson's, published in the March 2019 issue of the Movement Disorders journal. Read the article
undefined
Feb 20, 2019 • 0sec

Is benign hereditary chorea really benign?

Dr. Mered Parnes discusses with Dr. Sara Schaefer his article on benign hereditary chorea recently published in the January 2019 issue of the Movement Disorders Clinical Practice. Read the article

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app